Trial Profile
Study in Patients With COPD.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Formoterol (Primary) ; Antihistamines
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 27 Dec 2007 Status changed from in progess to completed as reported by ClinicalTrials.gov.
- 05 Nov 2005 New trial record.